All
Bristol-Myers Squibb and Samsung BioLogics Expand Manufacturing Agreement
Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.
Splice Variants Reveal Autism Gene Connections
Research reveals that proteins involved in autism interact with many more partners than previously known.
Novartis and GSK Trade Assets
Portfolio swaps between Novartis and GSK involve oncology, vaccines, and consumer products.
Silly Putty Ingredient Spurs Stem Cell Growth
University of Michigan study demonstrates how a Silly Putty ingredient could advance stem cell therapies.
Lilly to Acquire Novartis Animal Health
Eli Lilly will acquire Novartis Animal Health for approximately $5.4 billion.
Virus-Fighting Genes Linked to Cancer
Genetic evidence supports role of APOBEC gene family in cancer development.
Eli Lilly's Cyramza Receives FDA Approval for Treatment of Advanced Gastric Cancer
Lilly1s Cyramza is the first FDA-approved treatment for advanced gastric cancer after prior chemotherapy.
Aastrom Biosciences Acquires Sanofi's Cell Therapy and Regenerative Medicine Business
Aastrom Biosciences will acquire Sanofi's CTRM business for $6.5 million.
Novartis's Bexsero Receives FDA Breakthrough Therapy Designation
Novartis receives FDA breakthrough therapy designation for Bexsero, a meningitis B vaccine.
DepoVax Technology Selected for HPV–related Cancer Trials
Immunovaccine's vaccine technology chosen for cervical, head, and neck cancer trials conducted by Dana-Farber Institute.
EMA Warns of Falsified Herceptin Vials
EMA notifies EU healthcare professionals of the falsified cancer drug Herceptin.
Mallinckrodt to Acquire Questcor Pharmaceuticals
Mallinckrodt will acquire Questcor to create a diversified, high-growth specialty pharmaceuticals company.
Center for Biologics Evaluation and Research Relocates
CBER will move to the FDA White Oak campus in Silver Spring, Maryland.
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
A new report from PhRMA outlines potential growth trajectories affecting the biopharmaceutical industry.
PolyTherics and MacroGenics Extend ADC Collaboration
ThioBridge linker technology to attach different payloads to a range of antibodies
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
Biotechnology developer American CryoStem and Rutgers University partner on stem-cell platform technology development.
FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines
FDA develops an assay that could speed the release of pandemic influenza vaccines.
uniQure Announces Management Changes
uniQure appoints a new COO and vice president, Medical affairs.
Desktop Human Body Developed for Toxicity Testing
The Advanced Tissue-engineered Human Ectypal Network Analyzer project team is developing realistic human organs for testing.
Lilly To Release Data Targeting Key Cancer Pathways At AACR 2014
Eli Lilly will present early-stage data regarding cancer therapies at AACR 2014.
Merck Announces Management Changes
Merck promotes internal managers to head Merck Millipore and Consumer Health Divisions.
Sun Pharma to Acquire Ranbaxy
Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.
A New Plant Biotech Approach for Efficient Production of Pharmaceutical Compound
European scientists have discovered a method to improve the efficiency of the pharmaceutical production through plant biotechnology.
Recurrent Head and Neck Tumors Could be Vulnerable to Cancer Drug
New research finds that recurrent head and neck tumors have gene mutations that could be vulnerable to the cancer drug dasatinib.
Immunovaccine Presents New Cancer Vaccine Data at AACR
Immunovaccine reports enhanced cancer vaccine combination therapies at 2014 AACR Annual Meeting.
Genzyme to Resubmit Lemtrada Application for FDA Review
Sanofi and Genzyme to resubmit FDA application for approval of Lemtrada, for the treatment of relapsing forms of multiple sclerosis.
Novartis and Malaria No More Campaign Provide Antimalarial Treatments in Zambia
Novartis delivers 2 million treatments of its pediatric antimalarial to Zambia in collaboration with Malaria No More's Power of One campaign.
Vetter Implements New Serialization Services
Vetter launches new serialization process to support track-and-trace efforts.
Regulatory Compliance Associates Expands into Poland
RCA opens a new office in Warsaw, Poland.
